Orbis Biosciences (United States)
Corporate R&D · Kansas City, United States · Founded 2007
Website: orbisbio.com. Lenexa pharmaceutical technology company developing customized formulations and IP; acquired by Adare Pharmaceuticals in May 2020.
Closed or ended, checked October 13, 2026.
In context
Orbis Biosciences (United States) is one of 10,487 corporate R&D centers in the United States listed in the Innovative EcoSystems registry.
The registry lists 46 innovation ecosystem organizations in Kansas City, Kansas in all.
Corporate R&D centers are where established companies develop new products and processes, often in partnership with universities and startups.
The United States scores 68.5 out of 100 on the IEPA (2024 edition), ranking 21 of 117 economies.
See the United States on the IEPA ↗
More corporate R&D centers in Kansas City, Kansas
- Rainbow Communications (United States)
Kansas City
Elsewhere in Kansas City, Kansas
- Pipeline Entrepreneurs
Accelerator - Polsinelli
Company - Wyandotte Economic Development Council
Government or public body - Retina Associates
Health research - Patterson Family Foundation
Investor or fund - KCSourceLink
Network or association - Kansas City, Kansas Public Library
Organization - Kauffman FastTrac
Program
More corporate R&D centers in the United States
- Orion Genomics (United States)
St Louis - ATEC (United States)
College Park - Vashon Partners (United States)
Seattle - Indivior (United States)
Chesterfield - GTT Communications (United States)
Tysons Corner - Molecular Theranostics (United States)
Cleveland - Bradenton Neurology
Bradenton - Merit Medical (United States)
South Jordan